1. The Merck West Point facility link
What is true:
Merck has large vaccine manufacturing facilities at West Point, PA.
Project 63A / B63A expanded pre-filled syringe capacity for vaccines.
Merck produces pneumococcal vaccines (Prevnar, Pneumovax, V116 / Capvaxive).
What is not proven:
There is no evidence that these facilities are being used to manufacture DCVax-L.
There is no evidence of a manufacturing, licensing, or supply agreement between NWBO and Merck.
Large pharma expands vaccine capacity all the time for their own pipelines.
➡️ Conclusion:
Merck building vaccine capacity ? Merck partnering with NWBO.
This is a classic “big company proximity fallacy”:
“They’re nearby / mentioned in the same context ? therefore they’re connected.”
2. Pneumococcal vaccines in dendritic-cell trials
This is where the post sounds convincing.
Yes, pneumococcal vaccines (Prevnar / Pneumovax) were used in multiple DC trials.
But:
Why they were used
Pneumococcal vaccines are often used as:
immune stimulants / adjuvants
immune competence tests
recall antigens
They help assess or boost antigen presentation, not treat cancer directly.
This has been standard immunology practice for decades, across:
Academic trials
NIH-funded studies
Multiple cancer vaccine platforms
Key point:
These trials do not belong to NWBO, and
they do not imply Merck endorsement, collaboration, or interest in DCVax-L.
➡️ Using Prevnar in trials ? Merck validating DCVax-L
➡️ Merck manufacturing Prevnar ? Merck manufacturing DCVax
3. The “Dr. Bosch NYAS ‘I = V116’” claim
This is the weakest part.
Interpreting a single letter (“I”) from a presentation slide
Mapping it to V116 / PCV21
Then mapping that to specific Merck buildings
Then mapping that to NWBO
This is pure speculation, not inference.
There is:
No documentation
No confirmation
No regulatory filing
No trial registry
No manufacturing disclosure
➡️ This is pattern-seeking, not evidence.
4. Emotional language = red flag
Phrases like:
“generational wealth”
“first real cancer cure in human history”
“how could we not be rewarded”
“brag to my grandchildren”
These are classic pump-board signals, especially in biotech.
Legitimate breakthroughs are discussed in:
Trial endpoints
OS/PFS data
Regulatory milestones
Manufacturing validation filings
Not moral entitlement narratives.
5. What would real confirmation look like?
If this were real, you would see at least one of the following:
SEC filings (8-K) mentioning Merck
Manufacturing agreements disclosed
Regulatory inspection records tied to NWBO
Merck press releases
Supply chain disclosures
Trial protocol amendments naming Merck
None exist.
Final verdict
Is he right this time?
➡️ No, not in any actionable or evidentiary way.
Is it total nonsense?
➡️ Not completely — the background facts about vaccines and immune modulation are real.
But the conclusion is unsupported.
This is confirmation bias + promotional storytelling, not due diligence.
If NWBO ever becomes real value, it will be because of:
Peer-reviewed survival data
Regulatory approval
Transparent manufacturing pathways
Not because Merck built a syringe line and someone connected dots on a message board.
Market Data 
Markets 
AI
